PYAMA: Pranayama Practice on the Autonomic Nervous System

Sponsor
National University of Natural Medicine (Other)
Overall Status
Unknown status
CT.gov ID
NCT03280589
Collaborator
(none)
40
1
5
16
2.5

Study Details

Study Description

Brief Summary

The proposed study design will be a randomized, cross-over trial testing different pranayama breathing interventions. Participants (N=40) will perform each of the following five interventions in a randomly assigned order: (1) internal-paced pranayama intervention (Sheetali/Sheetkari for 10 minutes each) (2) internal-paced deep breathing control (3) external-paced pranayama intervention at a rate of 6 bpm (4) external-paced deep breathing at a rate of 6 bpm (5) sitting quietly with no external instruction.

Condition or Disease Intervention/Treatment Phase
  • Other: Sheetali/Sheekari Pranayama
  • Other: Sitting Quietly
  • Other: Deep breathing
Early Phase 1

Detailed Description

Healthy adult participants (N=40) will be recruited from the general population. Potential participants will contact a study phone line or email expressing their interest, and they will then be contacted in order to schedule a screening telephone interview for an initial assessment of their eligibility. Recruitment will be conducted in the general community using flyers, newspaper advertisements, radio advertisements, and web advertising. NUNM students, faculty, staff and patients will not be specifically targeted for recruitment, although they may see a posted flyer and decide to contact study staff.Screening for potential participants will occur over the phone, using a standardized telephone script and during the first study visit. Prior to all clinical research visits, participants will be called and reminded how to prepare, i.e., avoid extreme physical exercise for one day and refrain from alcohol, caffeinated beverages, and recreational drugs for twelve hours before coming to clinic. The participant will be queried about alcohol, caffeinated beverages, over-the-counter medications, and recreational drugs at the beginning of each visit. If they are not compliant with these instructions, they will be asked to either reschedule their visit until they report compliance or withdraw from the study if compliance is not feasible.

  • Height and weight will be measured and recorded and BMI will be calculated (Visit 1 only, if out of range then participant does not meet inclusion criteria and will not be enrolled).

  • Heart rate (HR) and blood pressure (BP) will be recorded after the volunteer has been sitting calmly for 5 minutes. The mean of 3 successive recordings with at least 2 minutes between readings will be calculated and recorded as the BP and HR for the visit. (Visit 1 only if out of range then participant does not meet inclusion criteria and will not be enrolled)

  • Participants will fill out the pretreatment Mind Body Awareness (visit one and five only) and the Positive Affect Negative Affect Scale (PANAS) questionnaires in order to assess baseline mood.

  • Participants will be connected to the ProComp8 infinity Encoder (Thought Technologies) for physiological measurements of EKG (for HR and HRV). For EKG measurement electrodes will be placed on the wrist using adjustable bands. For respiratory measurements thoracic and abdominal sensors will go around the body.

  • The order of the following conditions will be randomly assigned (1) self-paced pranayama intervention (Sheetali/Sheetkari consecutively for 10 minutes each) (2) self-paced deep breathing control (3) external-paced pranayama intervention at a rate of 6 bpm (4) external-paced deep breathing at a rate of 6 bpm (5) sitting quietly with no external instruction.

  • Before and after measurements will be recorded with the participant's eye open and focused on a on screen image and with eyes closed. This is a common practice in the measurement of EEG due to shifts in Alpha state brain waves when the eyes are closed.

  • Each session will follow the pattern below:

  1. Pre- PANAS questionnaire

  2. Intro screen (one activity)

  1. Reviews activities with the participant
  1. Sensor placement

  2. Respiration instructions

  3. EKG instructions

  4. EEG instructions

  5. Eyes open before

  6. Instructions

  7. Measurement

  8. Eyes closed before

  9. Instructions

  10. Measurement

  11. Breathing exercise (Activities unique to each condition with video instructions)

  12. Instructions

  13. Video instructed breath measurement

  14. Eyes open after

  15. Instructions

  16. Measurement

  17. Eyes closed after

  18. Instructions

  19. Measurement

  20. Removal of sensors

  1. Instruction
  1. Post PANAS questionnaire
  • Throughout the session participants will be comfortably seated in a chair and instructed to keep their spine erect. The total duration of each HRV measurement will be about 40 minutes: 10 minutes before the practice, 20-minute video with instructions for each condition (broken up into 5 min sections to allow rest), and 10 minutes after the practice.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
The Effect of Respiration Rate During Pranayama Practice on the Autonomic Nervous System
Actual Study Start Date :
Aug 15, 2017
Anticipated Primary Completion Date :
Dec 15, 2018
Anticipated Study Completion Date :
Dec 15, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Sitting Quietly

Participants will be instructed to sit comfortably in a chair with both feet flat on the floor, hands on their lap or thighs, rest their eyes (closed or slightly open gazed cast down), release tension in the body, remain still, and allow the chair to support them. Instructions will be displayed to them with on-screen video segments while the study personnel helps explains the steps, answers questions, and monitors adherence. There will be 4 five-minute sessions with a one-minute break in between to allow the participant to rest, adjust posture, and answer any questions. The total duration of this session will be approximately 40 minutes.

Other: Sitting Quietly
Participant breaths in their natural way with out instruction

Experimental: Deep Breathing Self Paced

Participants will be instructed to sit comfortably in a chair with both feet flat on the floor, hands on their lap or thighs, rest their eyes (closed or slightly open gazed cast down), release tension in the body, remain still, and allow the chair to support them. There will be 4 five-minute sessions with a one-minute break in between to allow the participant to rest, adjust posture, and answer any questions. Instruction will be displayed to them with on-screen video segments while the study personnel helps explains the steps, answers questions, and monitors adherence. The total duration of this session will be approximately 40 minutes.

Other: Deep breathing
Participant is required to pay attention to each breath

Experimental: Deep Breathing Externally paced

Participants will have an instructional video with auditory queues prompting them to inhale and exhale at 6 bpm (approximately 4 seconds between inhale and exhale). Participants will be instructed to sit comfortably in a chair with both feet flat on the floor, hands on their lap or thighs, rest their eyes (closed or slightly open gazed cast down), release tension in the body, remain still and allow the chair to support them. There will be 4 five-minute sessions with a one-minute break in between to allow the participant to rest, adjust posture, and answer any questions. Instruction will be displayed to them with on-screen video segments while the study personnel helps explains the steps, answers questions, and monitors adherence. The total duration of this session will be approximately 40 minutes.

Other: Deep breathing
Participant is required to pay attention to each breath

Experimental: Sheetali/Sheetkali, self-paced:

Participant will follow on-screen instructions for Sheetali/Sheetkari with shaped lips/mouth as indicated (i.e., inhaling through the mouth held specific to each practice and exhaling through nostrils), fully filling and emptying the lungs with each breath. In Sheetali, the tongue is allowed to protrude from the mouth at a comfortable distance and rolled into a tube. Following 10 minutes of Sheetali practice, participants will have a one minute rest followed by Sheetkari. In Sheetkari, the tongue is not rolled into a tube; instead, it is rolled up to touch the upper palate. The teeth are then exposed and the lips are kept apart for inhalation and the mouth is closed, tongue is relaxed, and exhalation occurs through the nose. Study personnel will monitor their posture and breathing rate and pause the recording if additional coaching is necessary. The total duration of this session will be approximately 40 minutes.

Other: Sheetali/Sheekari Pranayama
Most pranayama involves (1) sitting quietly, (2) deep breathing (completely filling and emptying the lungs, at a slow/comfortable pace, with awareness), and (3) a specific mouth, tongue, lip and/or body shape, theorized to enhance the effects of the practice. Practitioners of pranayama modulate the cycles of inspiration and expiration, in a way that is theorized to achieve influence over autonomic functions such as heart rate, heart rate variability (HRV), and baroreflex [6]. For example, the manipulation of the tongue and face during Sheetali and Sheetkari pranayama is intended to stimulate parasympathetic nervous system activity and inhibit the sympathetic nervous system.
Other Names:
  • Pranayama deep breathing
  • Other: Deep breathing
    Participant is required to pay attention to each breath

    Experimental: Sheetali/Sheetkari, externally-paced

    The participant will follow on screen instruction for Sheetali/Sheetkari with shaped lips/mouth as indicated, fully filling and emptying the lungs with each breath. The tongue is allowed to protrude from the mouth at a comfortable distance and rolled into a tube. Following 10 minutes of Sheetali practice, participants will have a one-minute rest before continuing. In Sheetkari the teeth are exposed and the lips are kept apart for inhalation and the mouth is closed, tongue is relaxed, and exhalation occurs through the nose. Instruction will be displayed to them with on-screen video segments while the study personnel helps explains the steps, answers questions, and monitors adherence. There will be an auditory queue to prompt the participant to breathe in and out. Study personnel will monitor their posture and breathing rate and pause the recording if additional coaching is necessary.The total duration of this session will be approximately 40 minutes.

    Other: Sheetali/Sheekari Pranayama
    Most pranayama involves (1) sitting quietly, (2) deep breathing (completely filling and emptying the lungs, at a slow/comfortable pace, with awareness), and (3) a specific mouth, tongue, lip and/or body shape, theorized to enhance the effects of the practice. Practitioners of pranayama modulate the cycles of inspiration and expiration, in a way that is theorized to achieve influence over autonomic functions such as heart rate, heart rate variability (HRV), and baroreflex [6]. For example, the manipulation of the tongue and face during Sheetali and Sheetkari pranayama is intended to stimulate parasympathetic nervous system activity and inhibit the sympathetic nervous system.
    Other Names:
  • Pranayama deep breathing
  • Other: Deep breathing
    Participant is required to pay attention to each breath

    Outcome Measures

    Primary Outcome Measures

    1. Change in Heart Rate Variability (HRV) [Before and after 20 minutes of breathing excersise]

      Analysis of EKG spectra before and after the session

    Secondary Outcome Measures

    1. Change in EEG [Before and after 20 minutes of breathing excersise]

      Analysis of EEG spectra before and after the session

    Other Outcome Measures

    1. Change in PANAS Questionnaire [Before and after 20 minutes of breathing excersise]

      Mood Evaluation

    2. Change Mindfullness Questionnaire [Before and after 20 minutes of breathing excersise]

      Evaluation of body awareness

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 55 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Able to roll tongue into tube (queried over the phone and reassessed at visit 1)

    • Age ≥ 25 and ≤ 55 (HRV and other ANS parameters change significantly during the aging process)

    • BMI ≥ 18.5 and ≤ 34.9 (Body weight effects HRV and ANS parameters)

    • Willing and able to give informed consent

    • Able to follow protocol and attend visits

    • Able to read and write English

    • Able to abstain from over-the-counter painkillers like NSAIDs and allergy medications for 24 hours (Zyrtec and Claritin)

    Exclusion Criteria:
    • A regular practice of yoga, meditation, and/or breathing more than once a week (Individuals that have conditioned their ANS through yoga, meditation, and breathing exercise may not respond to the breathing condition like the representative population)

    • Formal (Yoga Alliance Sanctioned 200h or 500h course or other comparable ) training in yoga, Mindfulness-Based Stress Reduction, transcendental meditation, Qigong, Tai Chi, and/or other forms of meditation/consciousness expansion practices (Individuals that have conditioned their ANS through yoga, meditation, and breathing exercise may not respond to the breathing condition like the representative population)

    • A recent cardiovascular event (e.g. myocardial infarction, stroke ≤ six months prior to screening visit), current coronary artery disease, angina, stage III or IV congestive heart failure, or stated history of coronary bypass surgery or heart stent placement

    • Presence of a cardiac pacemaker

    • History of cardiovascular disease, including heart arrhythmias and prehypertension (systolic BP > 140 mmHg or diastolic BP >90) or hypotension (systolic BP < 90 mmHg or diastolic BP <60)

    • Taking prescription drugs that may interfere with heart, nervous, and respiratory rhythms, beta blockers, pain medications, SSRIs, anti-cholinergics, or anxiety medication

    • Started or changed the dosage of supplements or medications within the last month

    • Open skin rashes and sores that may interfere with placement of sensors

    • History of emphysema, chronic bronchitis or bronchiectasis and/or asthma (with FEV1/FVC < 80%) within in the last six months or taking medication to control asthma symptoms

    • History of Diabetes type 1 or 2 (> 5 year duration of type 2 diabetes or > 10 years duration of type 1 diabetes (due to the potential for autonomic neuropathy)

    • History of or current epilepsy or other seizure disorder(s)

    • Current diagnosis of mental illness for which the participant is currently taking prescription medications

    • Smoking of tobacco products in a the last 6 months

    • Pregnant, nursing, or planning a pregnancy within the next 6 weeks (due to pregnancy-induced changes in HRV

    • Presence of any unstable and/or significant medical disorder that would compromise the participant's safety to take part in the trial. Such disorders include any known event that will require beginning new medications and/or prevent adherence to the schedule of study activities over the following 6 weeks

    • Chronic hyperventilation (Access by NQ during telephone screen)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 National University of Natural Medicine Portland Oregon United States 97201

    Sponsors and Collaborators

    • National University of Natural Medicine

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Alison Lacombe, R90 Fellow, National University of Natural Medicine
    ClinicalTrials.gov Identifier:
    NCT03280589
    Other Study ID Numbers:
    • PYAMA
    First Posted:
    Sep 12, 2017
    Last Update Posted:
    Sep 12, 2017
    Last Verified:
    Sep 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Alison Lacombe, R90 Fellow, National University of Natural Medicine
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 12, 2017